Contract Services Contract Research

Australian Neuren Phase 2 Trial Reveals Significant Improvements in Phelan-McDermid Syndrome

Highlights:  Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures   Improvements were con...

 December 19, 2023 | News

Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million...

 November 30, 2023 | News

Is Asia ready to be the next global biotech hub?

  As outlined in Cytiva’s 2023 Global Biopharma Resilience Index, economies such as Singapore, South Korea, Japan and Australia, are able to pr...

 November 28, 2023 | Opinion | By Prem Mandalapu, Commercial General Manager, ASEAN, Cytiva

WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange

WuXi XDC issued a total of 178,446,000 shares under the global offering at an offer price of HK$20.60 per share (being the high-end of the indica...

 November 20, 2023 | News

XINGIMAGING and MITRO BIOTECH Merge for Global CRO Operations

As a combined company, Mitro will expand its capabilities to provide full CRO services, including clinical and clinical imaging management, in China&n...

 October 24, 2023 | News

Cameron Smith Appointed as Chief Business Development Officer for Agilex Biolabs

Cameron brings a wealth of experience in the Bioanalytical field, with a particular focus on Toxicology. His extensive knowledge and global market expertis...

 October 17, 2023 | News

Navin Fluorine International Ltd. unveils "Navin Molecular" as the new brand for its innovative CDMO business

The new brand is being launched to showcase the broad platform that Navin Molecular can offer and will focus on two key value propositions.  Firstly, ...

 October 17, 2023 | News

WuXi Biologics Introduces WuXiUI™: Enhancing Bioprocessing for Efficiency and Quality in Commercial Manufacturing

WuXiUI™ ultra-intensified fed-batch platform offers a new process option for maximum flexibility to meet various clients' needs in biologics d...

 October 17, 2023 | News

ABL Bio Achieves Regulatory Clearance for Innovative Bispecific Antibody in Solid Tumor; GenScript ProBio Commends Milestone Collaboration

ABL103 is a novel T-cell engaging bispecific antibody and demonstrates efficacious anti-tumor activity via B7-H4 mediated 4-1BB activation in tumor mi...

 October 13, 2023 | News

Dirk Lange Reveals Merck's Historic Leap as the First CTDMO to Offer Integrated mRNA Services: A Blueprint for Advancing Biopharma

In this interview, we explore the significance of Merck's €1 billion investment in advancing mRNA technologies, the impact of their acqu...

 October 11, 2023 | News

Emmes acquires VaxTRIALS

 Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical inn...

 October 06, 2023 | News

WuXi Bio Applauds Amicus on FDA Approval for Pompe Disease Therapy

Pombiliti™, a recombinant human GAA enzyme (rhGAA) naturally expressed with high levels of bis-M6P (Mannose 6-Phosphate), was started at WuXi Biologi...

 October 02, 2023 | News

Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services

Cellectricon, a services provider dedicated to advancing neuroscience drug discovery,  announced the launch of a new service module for neuroplasticit...

 September 27, 2023 | News

Merck to Become First Provider to Offer Fully Integrated mRNA Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...

 September 27, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close